India Exchange Filings

India Glycols Q2 & H1 FY27 Investor Presentation

India Glycols Ltd presents Q2 and H1 FY27 results, with Q2 revenue of ₹358 crore and EBITDA of ₹52 crore

  • Q2 revenue rose 30% year on year; EBITDA increased 26%, with a 14.6% margin.
  • H1 revenue was ₹713 crore, up 26%; EBITDA was ₹113 crore, up 25%, at a 15.8% margin.
  • Comparative figures are like-for-like following the demerger of the spirits, bio-fuels and biopharma businesses.

Original Filing

This is an automated summary of a public document. Always check the original before relying on it.